PJP - Latest News
Invesco Pharmaceuticals ETF (PJP), operates in Financial Services / Asset Management, trades on AMEX.
Market capitalization stands near $357.8M, a proxy for assets under management on listed ETFs.
The article list below shows the most recent PJP headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent PJP Headlines
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
zacks.com - Sep 28, 2026
The Invesco Pharmaceuticals ETF (PJP) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Hea
XLV vs. PJP: How Broad Healthcare Diversification Stacks Up to Pharma Stocks
fool.com - Sep 23, 2026
The State Street Health Care Select Sector SPDR ETF (XLV) offers significantly lower ownership costs, with an expense ratio of 0. 08% compared to 0.
Invesco Pharmaceuticals vs iShares Healthcare: Which Healthcare ETF Brings Better Profits
fool.com - Sep 8, 2026
Invesco's concentrated 30-stock pharma fund delivered 43. 1% returns last year, but iShares' broader 100-holding portfolio costs less and offers wider
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
zacks.com - Sep 3, 2026
Launched on June 23, 2005, the Invesco Pharmaceuticals ETF (PJP) is a passively managed exchange traded fund designed to provide a broad exposure to t
Bank of America Corp DE Has $7.73 Million Stock Holdings in Invesco Pharmaceuticals ETF $PJP
defenseworld.net - Aug 26, 2026
Bank of America Corp DE raised its stake in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP) by 234. 0% during the first quarter, according to its
How News Affects PJP Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track PJP's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked PJP news questions
- What is the latest PJP news headline?
- The most recent PJP headline (Sep 28, 2026) is "Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the PJP news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What PJP news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual PJP options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.